Hepatitis C: Serological and molecular diagnosis and genotype in haemophilic patients at the Regional Hemocenter of Maringá, Maringá PR Brazil

Haemophilia

Volumn 14, Issue 4, 2008, Pages 810-815

  Ferreira, M R M N ^a   Lonardoni, Maria Valdrinez Campana ^a   Bertolini, D A ^a  

^a STATE UNIVERSITY OF MARINGÁ   (Brazil)

Author keywords

Genotypes; Haemophilia; Hepatitis C; Hepatitis C virus; Predominance

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BLOOD CLOTTING FACTOR 8; BLOOD CLOTTING FACTOR 9; HEPATITIS C ANTIBODY; VIRUS RNA;

ADOLESCENT; ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BLOOD TRANSFUSION; BRAZIL; CHILD; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; DISEASE SEVERITY; ENZYME IMMUNOASSAY; GENOTYPE; HEMOPHILIA A; HEMOPHILIA B; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; SERODIAGNOSIS; VIRUS DETECTION;

EID: 47649117995     PISSN: 13518216     EISSN: 13652516     Source Type: Journal    
DOI: 10.1111/j.1365-2516.2008.01676.x     Document Type: Article

References (34)

1. Madhava V, Burgess C, Drucker E. Epidemiology of chronic hepatitis C virus infection in sub-Saharan Africa. Lancet Infect Dis 2002; 2: 293-302.
2. Campiotto S, Pinho JRR, Carrilho FJ et al. Geographic distribution of hepatitis C virus genotypes in Brazil. Braz J Med Biol Res 2005; 38: 41-9.
3. Peres LVC. Análise genotípica do vírus da hepatite C em crianças e adolescentes hemofílicos brasileiros. Doctoral Thesis in Medicine. São Paulo: Setor de Pediatria, Universidade Federal de São Paulo, 2000: 121 pp.
4. Eyster ME, Sanders J, Goedert JJ. Viral clearance occurs very early during the natural resolution of hepatitis C virus infection in persons with haemophilia. Haemophilia 2004; 10: 75-80.
5. Posthouwer D, Wolters VM, Fischer K, Houwen RHJ, van Den Berg HM, Mauser-Bunschoten EP. Hepatitis C infection in children with haemophilia: A pilot study. Haemophilia 2004; 10: 722-6.
6. Brandão-Mello CE, Gonçalves ECM, Silva AEB. HCV e Hemofilia. In: Focaccia R, ed. Tratado de hepatites virais, 1st edn. São Paulo: Atheneu, 2003: 281-9.
7. Goedert JJ. Prevalence of conditions associated with human immunodeficiency and hepatitis virus infectious among persons with haemophilia, 2001-2003. Haemophilia 2005; 11: 516-28.
8. Zhang M, Rosenberg PS, Brown DL et al. Correlates of spontaneous clearance of hepatitis C virus among people with hemophilia. Blood 2006; 107: 892-7.
9. Maor Y, Bashari D, Kenet G et al. Hepatitis C at the Israeli National Hemophilia Center. Haemophilia 2006; 12: 68-74.
10. Silva LK, Silva MBS, Lopes GB et al. Prevalência da infecção pelo vírus da hepatite C e genótipos entre hemofílicos no estado da Bahia, nordeste do Brasil: análise de parâmetros sorológicos e virológicos. Rev Soc Bras Med Trop 2005; 38: 496-502.
11. Posthouwer D, Plug I, van Der Bom JG, Fischer K, Rosendaal FR, Mauser-Bunschoten EP. Hepatitis C infection among Dutch haemophilia patients: A nationwide cross-sectional study of prevalence and antiviral treatment. Haemophilia 2005; 11: 270-5.
12. Evatt BL, Farrugia A, Shapiro AD, Wilde JT. Haemophilia 2002: Emerging risks of treatment. Haemophilia 2002; 8: 221-9.
13. BRASIL Ministério da Saúde. Secretaria de Vigilância Sanitária. Portaria no 488, de 17 de junho de 1998. Diário Oficial da União. República Federativa do Brasil, Imprensa Nacional, Brasília, DF, Seção, 1, 18 de junho, 1998: P. 3-4.
14. Franchini M, Rossetti G, Tagliaferri A et al. The natural history of chronic hepatitis C in a cohort of HIV-negative Italian patients with hereditary bleeding disorders. Blood 2001; 98: 1836-41.
15. Focaccia R, Baraldo DCOM, Souza FV. Epidemiologia. In: Focaccia R, ed. Tratado de hepatites virais, 1st edn. São Paulo: Atheneu, 2003: 221-229.
16. BRASIL. Ministério da Saúde. Gabinete do Ministro. Portaria n°1376, de 19 de novembro de 1993. Diário Oficial da União. República Federativa do Brasil, Imprensa Nacional, Brasília, DF, Seção, 1, 2 de dezembro, 1993: P. 18404.
17. Ferraz MLG, Oliveira PM. Diagnóstico Laboratorial Específico. In: Focaccia R, ed. Tratado de hepatites virais, 1st edn. São Paulo: Atheneu, 2003: 209-14.
18. Strauss E. Hepatite C. Rev Soc Bras Med Trop 2001; 34: 69-82.
19. Katsoulidou AS, Moschidis ZM, Gialeraki RE et al. Clinical evaluation of an HIV-1 and HCV assay and demonstration of significant reduction of the HCV detection window before seroconversion. Transfusion 2004; 44: 59-66.
20. Laperche S, Elghouzzi MH, Morel P et al. Is an assay for simultaneous detection of hepatitis C virus core antigen and antibody a valuable alternative to nucleic acid testing? Transfusion 2005; 45: 1965-72.
21. Spiess BD. Risks of transfusion: Outcome focus. Transfusion 2004; 44(Suppl.): 4S-14S.
22. Carmo RA, Oliveira GC, Guimarães MDC et al. Hepatitis C virus infection among Brazilian hemophiliacs: A virological, clinical and epidemiological study. Braz J Med Biol Res 2002; 35: 589-98.
23. Peres LVC, Succi RCM, Bensabath G, Soares MCP, Saraiva ASL. Hepatite pelo vírus C [HCV] em crianças e adolescentes hemofílicos. J Pediatr, Rio de Janeiro, 1998; 74: 325-32.
24. Carmo RA. Estudo da prevalência e genotipagem do vírus da hepatite C em população hemofílica, Minas Gerais, 1997. Belo Horizonte, Master's Thesis in Medicine, Minas Gerais: Faculdade de Medicina da Universidade Federal de Minas Gerais, 1999.
25. Barbosa AP, Martins RMB, Teles SA, Silva SA, Oliveira JM, Yoshida CFT. Prevalence of hepatitis C virus infection among Hemophiliacs in Central Brazil. Mem Inst Oswaldo Cruz 2002; 97: 643-4.
26. Remesar M, Gamba C, Kuperman S et al. Antibodies to hepatitis C and other viral markers in multi-transfused patients from Argentina. J Clin Virol 2005; 34(Suppl. 2): S20-6.
27. Laguna-Torres VA, Pérez-Bao J, Chauca G et al. Epidemiology of transfusion-transmitted infections among multi-transfused patients in seven hospitals in Peru. J Clin Virol 2005; 34(Suppl. 2): S61-8.
28. López L, López P, Arago A et al. Risk factors for hepatitis B and C in multi-transfused patients in Uruguay. J Clin Virol 2005; 34(Suppl. 2): S69-74.
29. Beltrán M, Navas MC, De la Hoz F et al. Hepatitis C virus seroprevalence in multi-transfused patients in Colombia. J Clin Virol 2005; 34(Suppl. 2): S33-8.
30. Brettler DB, Alter HJ, Dienstag JL, Forsberg AD, Levine PH. Prevalence of hepatitis C virus antibody in a cohort of hemophilic patients. Blood 1990; 76: 254-6.
31. Perret BA, Senn M, Affentranger P, Poorbeik M, Burckhardt JJ, Morell A. Seroprevalence of hepatitis C virus in hemophiliacs in Switzerland. Schweiz Med Wochenschr 1993; 123: 79-81.
32. Laurian Y, Blanc A, Delaney SR, Allain JP. All exposed hemophiliacs have markers of HCV. Vox San 1992; 62: 55-6.
33. Carvalho E. Hepatite C em hemofílicos: Aspectos epidemiológicos, laboratoriais e clínicos. Master's Dissertation at the Faculty of Health Sciences. Brazil: Universidade de Brasília, 1999.
34. Cavalheiro NP. Prevalência global de genótipos. In: Focaccia R, ed. Tratado de hepatites virais, 1st edn. São Paulo: Atheneu, 2003: 301-6.